Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders.

Vyas S, Javoy-Agid F, Herrero MT, Strada O, Boissiere F, Hibner U, Agid Y.

J Neurochem. 1997 Jul;69(1):223-31.

2.

I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.

Gargalidis-Moudanos C, Pizzinat N, Javoy-Agid F, Remaury A, Parini A.

Neurochem Int. 1997 Jan;30(1):31-6.

PMID:
9116585
3.

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y.

Histol Histopathol. 1997 Jan;12(1):25-31.

PMID:
9046040
4.

Clinical and pathological features in hydrocarbon-induced parkinsonism.

Pezzoli G, Strada O, Silani V, Zecchinelli A, Perbellini L, Javoy-Agid F, Ghidoni P, Motti ED, Masini T, Scarlato G, Agid Y, Hirsch EC.

Ann Neurol. 1996 Dec;40(6):922-5.

PMID:
9007099
5.

DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.

Chritin M, Blanchard V, Raisman-Vozari R, Feuerstein C, Agid Y, Javoy-Agid F, Savasta M.

Eur J Neurosci. 1996 Dec;8(12):2511-20.

PMID:
8996800
6.

Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.

Guridi J, Herrero MT, Luquin MR, Guillén J, Ruberg M, Laguna J, Vila M, Javoy-Agid F, Agid Y, Hirsch E, Obeso JA.

Brain. 1996 Oct;119 ( Pt 5):1717-27.

PMID:
8931592
7.

Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.

Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC.

Neurology. 1996 Jul;47(1):219-24.

PMID:
8710082
8.

Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.

Vila M, Herrero MT, Levy R, Faucheux B, Ruberg M, Guillen J, Luquin MR, Guridi J, Javoy-Agid F, Agid Y, Obeso JA, Hirsch EC.

Neurology. 1996 Mar;46(3):802-9.

PMID:
8618687
9.

Mitochondrial defect in Huntington's disease caudate nucleus.

Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH.

Ann Neurol. 1996 Mar;39(3):385-9.

PMID:
8602759
10.

Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia.

Griffon N, Crocq MA, Pilon C, Martres MP, Mayerova A, Uyanik G, Burgert E, Duval F, Macher JP, Javoy-Agid F, Tamminga CA, Schwartz JC, Sokoloff P.

Am J Med Genet. 1996 Feb 16;67(1):63-70.

PMID:
8678117
11.

Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.

Herrero MT, Levy R, Ruberg M, Javoy-Agid F, Luquin MR, Agid Y, Hirsch EC, Obeso JA.

Adv Neurol. 1996;69:209-16. No abstract available.

PMID:
8615130
12.

Is dopaminergic cell death accompanied by concomitant nerve plasticity?

Anglade P, Blanchard V, Raisman-Vozari R, Faucheux BA, Herrero MT, Obeso JA, Mouatt-Prigent A, Kastner A, Strada O, Javoy-Agid F, Agid Y, Hirsch EC.

Adv Neurol. 1996;69:195-208. Review. No abstract available.

PMID:
8615129
13.

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.

Herrero MT, Augood SJ, Hirsch EC, Javoy-Agid F, Luquin MR, Agid Y, Obeso JA, Emson PC.

Neuroscience. 1995 Oct;68(4):1189-98.

PMID:
8544992
14.

Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.

Faucheux BA, Herrero MT, Villares J, Levy R, Javoy-Agid F, Obeso JA, Hauw JJ, Agid Y, Hirsch EC.

Brain Res. 1995 Sep 11;691(1-2):115-24.

PMID:
8590043
15.

Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.

Levy R, Herrero MT, Ruberg M, Villares J, Faucheux B, Guridi J, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, et al.

Eur J Neurosci. 1995 Jun 1;7(6):1199-209.

PMID:
7582093
16.

Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain.

Blanchard V, Chritin M, Vyas S, Savasta M, Feuerstein C, Agid Y, Javoy-Agid F, Raisman-Vozari R.

J Neurochem. 1995 Apr;64(4):1669-79.

PMID:
7891094
17.

Dopamine denervation, age of onset, and Parkinson's disease.

Ruberg M, Scherman D, Javoy-Agid F, Agid Y.

Neurology. 1995 Feb;45(2):392. No abstract available.

PMID:
7854549
18.

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.

Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC.

Ann Neurol. 1995 Feb;37(2):265-72.

PMID:
7847868
19.

Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.

Levy R, Ruberg M, Herrero MT, Villares J, Javoy-Agid F, Agid Y, Hirsch EC.

Neurology. 1995 Jan;45(1):127-34.

PMID:
7824102
20.

Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.

Villares J, Strada O, Faucheux B, Javoy-Agid F, Agid Y, Hirsch EC.

Neurosci Lett. 1994 Nov 21;182(1):59-62.

PMID:
7891888
21.

Identification of new human myelin basic protein transcripts in the immune and central nervous systems.

Grima B, Zelenika D, Javoy-Agid F, Pessac B.

Neurobiol Dis. 1994 Nov;1(1-2):61-6.

PMID:
9216987
22.

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.

Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y.

Brain Res. 1994 Oct 3;659(1-2):1-9.

PMID:
7820649
23.

Galanin receptors in human hypothalamus: biochemical and structural analysis.

Lorinet AM, Javoy-Agid F, Laburthe M, Amiranoff B.

Eur J Pharmacol. 1994 Sep 15;269(1):59-64.

PMID:
7530206
24.

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD.

Ann Neurol. 1994 Sep;36(3):348-55.

PMID:
8080242
25.

Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system.

Kastner A, Anglade P, Bounaix C, Damier P, Javoy-Agid F, Bromet N, Agid Y, Hirsch EC.

Neuroscience. 1994 Sep;62(2):449-57.

PMID:
7830891
26.

Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.

Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y.

Ann Neurol. 1994 Aug;36(2):206-14.

PMID:
7914399
27.

Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.

Dournaud P, Cervera-Pierot P, Hirsch E, Javoy-Agid F, Kordon C, Agid Y, Epelbaum J.

Neuroscience. 1994 Aug;61(4):755-64.

PMID:
7838375
28.

Distribution of manganese-dependent superoxide dismutase in the human brain.

Zhang P, Anglade P, Hirsch EC, Javoy-Agid F, Agid Y.

Neuroscience. 1994 Jul;61(2):317-30.

PMID:
7969912
29.

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC.

Neurosci Lett. 1994 May 19;172(1-2):151-4.

PMID:
8084523
30.

Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.

Holemans S, Javoy-Agid F, Agid Y, De Paermentier F, Laterre EC, Maloteaux JM.

Brain Res. 1994 Apr 11;642(1-2):327-33.

PMID:
8032896
31.

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.

Uhl GR, Walther D, Mash D, Faucheux B, Javoy-Agid F.

Ann Neurol. 1994 Apr;35(4):494-8.

PMID:
8154880
32.

Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.

Blanchard V, Raisman-Vozari R, Vyas S, Michel PP, Javoy-Agid F, Uhl G, Agid Y.

Brain Res Mol Brain Res. 1994 Mar;22(1-4):29-38.

PMID:
7912404
33.

Cholinergic and peptidergic systems in PSP.

Javoy-Agid F.

J Neural Transm Suppl. 1994;42:205-18. Review.

PMID:
7964688
34.

Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.

Strada O, Hirsch EC, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y.

J Neurol Sci. 1993 Dec 1;120(1):33-7.

PMID:
8289077
35.

Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem.

Villares J, Faucheux B, Strada O, Hirsch EC, Agid Y, Javoy-Agid F.

Brain Res. 1993 Nov 19;628(1-2):72-6.

PMID:
8313172
36.
37.

Gangliosides and parkinsonism.

Herrero MT, Kastner A, Perez-Otaño I, Hirsch EC, Luquin MR, Javoy-Agid F, Del Río J, Obeso JA, Agid Y.

Neurology. 1993 Oct;43(10):2132-4.

PMID:
8413979
38.

[3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain.

Waeber C, Sebben M, Grossman C, Javoy-Agid F, Bockaert J, Dumuis A.

Neuroreport. 1993 Sep 10;4(11):1239-42.

PMID:
8219020
39.

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, Javoy-Agid F, Obeso JA, Agid Y.

Neuroscience. 1993 Sep;56(2):499-511.

PMID:
8247275
40.
41.

Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography.

Blanchard V, Raisman-Vozari R, Savasta M, Hirsch E, Javoy-Agid F, Feuerstein C, Agid Y.

J Neurochem. 1993 Aug;61(2):617-26.

PMID:
8101560
42.

In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels.

Herrero MT, Ruberg M, Hirsch EC, Mouatt A, Tobin AJ, Agid Y, Obeso JA, Javoy-Agid F.

Neurosci Lett. 1993 Jul 9;157(1):57-61.

PMID:
8233032
43.

Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon.

Zhang P, Damier P, Hirsch EC, Agid Y, Ceballos-Picot I, Sinet PM, Nicole A, Laurent M, Javoy-Agid F.

Neuroscience. 1993 Jul;55(1):167-75.

PMID:
8350985
44.

Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain.

Anglade P, Tsuji S, Hirsch EC, Javoy-Agid F, Agid Y.

Histol Histopathol. 1993 Jul;8(3):501-4.

PMID:
8102915
45.

Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.

Faucheux BA, Hirsch EC, Villares J, Selimi F, Mouatt-Prigent A, Javoy-Agid F, Hauw JJ, Agid Y.

J Neurochem. 1993 Jun;60(6):2338-41.

PMID:
8492137
46.

Adrenal transplant, dopaminergic neurons, and Parkinson's disease.

Anglade P, Hirsch EC, Brandel JP, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y.

Ann Neurol. 1993 Jun;33(6):662-3. No abstract available.

PMID:
8098934
47.

Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.

Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y.

Ann Neurol. 1993 May;33(5):445-50.

PMID:
8498822
48.

Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.

Lehéricy S, Hirsch EC, Cervera-Piérot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y.

J Comp Neurol. 1993 Apr 1;330(1):15-31.

PMID:
8468401
49.

Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.

Kastner A, Hirsch EC, Agid Y, Javoy-Agid F.

Brain Res. 1993 Mar 26;606(2):341-5.

PMID:
8098254
50.

Glutathione peroxidase, glial cells and Parkinson's disease.

Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F.

Neuroscience. 1993 Jan;52(1):1-6.

PMID:
8433802

Supplemental Content

Loading ...
Support Center